相关实验视频
Updated: Jun 30, 2025
09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
1.7K
对心力衰竭SGLT2抑制剂随机对照试验的质量报告:全面评估
YueGuang Yang1, ShunWen Yang1, YuBo Han2
1Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, 150040, People's Republic of China.
Scientific reports
|March 22, 2024
概括
在心力衰竭 (HF) 中,对-葡萄糖共运输蛋白2 (SGLT2) 抑制剂的随机对照试验 (RCT) 的报告质量不令人满意. 出版年份和样本大小等关键因素影响报告的完整性.
科学领域:
- 心脏病学 心脏病学
- 临床试验 临床试验
- 药理学 药理学是指药理学的学科.
背景情况:
- 随机对照试验 (RCT) 对于评估干预的有效性至关重要.
- 关于RCT的完整和透明报告对于批判性评估和临床应用至关重要.
- -葡萄糖共运输蛋白2 (SGLT2) 抑制剂正在越来越多地研究心力衰竭 (HF) 治疗.
研究的目的:
- 评估涉及高风暴SGLT2抑制剂的RCT报告质量.
- 确定与这些试验中报告质量的提高相关的因素.
主要方法:
- 在四个主要数据库中进行了全面的文献搜索.
- 2010年关于试验报告的综合标准 (CONSORT) 声明被用来通过25点的整体质量评分 (OQS) 来评估报告质量.
- 采用多变量回归建模来确定OQS的预测因素.
主要成果:
- 总共有58个相关的RCT被纳入分析.
- 中位数OQS为15 (范围7.5-24),表明报告不足最佳.
- 报告缺陷在"方法"和"结果"部分最常见.
- 最近出版的一年,高期刊影响因子和更大的样本大小预测了更高的OQS.
结论:
- 目前,关于高血压的SGLT2抑制剂报告的RCT的整体质量并不令人满意.
- 不完整的报告限制了这些重要的试验的批判性评估和临床实用性.
- 未来的研究应该专注于改善对报告准则的遵守,以提高证据的透明度.
相关概念视频
01:12Hazard Ratio
118
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
118
01:23Dipeptidyl Peptidase 4 Inhibitors
184
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
184
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
424
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
424
01:27Glucose Transporters
22.7K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.7K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126